Neoadjuvant therapy of metformin is associated with good tumor response after preoperative concurrent chemoradiotherapy for rectal cancer

Metformin is associated with good tumor response in preoperative concurrent chemoradiotherapy (CCRT) for rectal cancer. This study aims to demonstrate that the timing of metformin is related to the tumor response on preoperative CCRT for rectal cancer. From January 2010 to December 2017, 232 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jeonghee, Kim, Jong Ho, Lee, Jin-Won, Han, Sang Hyup, Kim, Haesung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904786/
https://www.ncbi.nlm.nih.gov/pubmed/35260687
http://dx.doi.org/10.1038/s41598-022-07768-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904786/
https://www.ncbi.nlm.nih.gov/pubmed/35260687
http://dx.doi.org/10.1038/s41598-022-07768-2

Ejemplares similares